FDA
-
-
-
-
-
-
-
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
-
-
-
-
-
-
-
Almirall's solid core business Q1 performance boosted by Growth drivers momentum
-
-
-
-
-
-
-
Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis
-
-
-
-
-
-
-
Almirall and Athenex Announce Positive Topline Results from Two Phase III Studies of KX2-391 Ointment 1% Featured in Late Breaker Program at the 2019 American Academy of Dermatology Annual Meeting
-
-
-
-
-
-
-
Sun Pharma Announces Twelve Tildrakizumab Abstracts to be Presented at American Academy of Dermatology 2018 Annual Meeting
-
-
-
-
-
-
322,242 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

